Adenoviral transfer of the murine oncostatin M gene suppresses dextran-sodium sulfate-induced colitis

Journal of Interferon and Cytokine Research

Volumn 23, Issue 4, 2003, Pages 193-201

  Sanchez, Ana L ^a   Langdon, Carrie M ^b   Akhtar, Mahmood ^a   Lu, Jun ^a   Richards, Carl D ^b   Bercik, Premysl ^a   McKay, Derek M ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DEXTRAN SULFATE; INTERLEUKIN 6; MYELOPEROXIDASE; ONCOSTATIN M;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL TYPE; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; GENETIC CODE; HISTOPATHOLOGY; INFLAMMATION; ION TRANSPORT; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM;

ACUTE-PHASE PROTEINS; ADENOVIRIDAE; ANIMALS; COLITIS; COLON; DEXTRAN SULFATE; GENETIC VECTORS; HUMANS; MALE; MICE; MICE, INBRED BALB C; ONCOSTATIN M; PEPTIDES; RECOMBINANT PROTEINS; TRANSFECTION;

ADENOVIRIDAE; ANIMALIA; MURINAE;

EID: 0038298907     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999003765027393     Document Type: Article

References (49)

1. PAPADAKIS, K.A., and TARGAN, S.R. (2000). Tumor necrosis factor: biology and therapeutic inhibitors. Gastroenterology 119, 1148-1157.
2. SCHREIBER, S., FEDORAK, R.N., NIELSEN, O.H., WILD, G., WILLIAMS, C.N., NIKOLAUS, S., JACYNA, M., LASHNER, B.A., GANGL, A., RUTGEERTS, P., ISAACS, K., VAN DEVENTER, S.J.H., KONINGSBERGER, J.C., COHARD, M., LEBEAUT, A., and HANAUER, S.B. (2000). Safety and efficiency of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology 119, 1461-1472.
3. HEINRICH, P.C., BEHRMANN, I., MULLER-NEWEN, G., SCHAPER, F., and GRAEVE, L. (1998). Interleukin-6-type cytokine signaling through gp130/Jak/Stat pathway. Biochem. J. 334, 297-314.
4. HERMANN, H.M., RADTKE, S., SCHAPER, F., HEINRICH, P.C., and BEHRMANN, I. (2000). Non-redundant signal transduction of interleukin-6-type cytokines. J. Biol. Chem. 27, 40742-40748.
5. ATREYA, R., MUDTER, J., FINOTTO, S., MULLBERG, J., JOSTOCK, T., WIRTZ, S., SCHUTZ, M., BARTSCH, B., HOLTMANN, M., BECKER, C., STRAND, D., CAZJA, J., SCHLAAK, J.F., LEHR, H.A., AUTSCHBACH, F., SCHURMANN, G., NISHIMOTO, N., YOSHIZAKI, K., ITO, H., KISHIMOTO, T., GALLE, P.R., ROSE-JOHN, S., and NEURATH, M.F. (2000). Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn's disease and experimental colitis in vivo. Nat. Med. 6, 583-588.
6. GADIENT, R.A., and PATTERSON, P.H. (1999). Leukemia inhibitory factor, interleukin 6, and other cytokines using the gp130 transducing receptor: roles in inflammation and injury. Stem Cells 17, 127-137.
7. TILG, H., DINARELLO, C.A., and MIER, J.W. (1997). IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol. Today 18, 428-432.
8. SHOYAB, M., MALIK, N., and WALLACE, P.M. (1988). Oncostatin M. In: Cytokines. A. Mire-Sluis and R. Thrope (eds.) New York: Academic Press, pp. 401-414.
9. WALLACE, P.M., MacMASTER, J.F., ROULEAU, K.A., BROWN, J.T., LOY, J.K., DONALDSON, K.L., and WAHL, A.F. (1999). Regulation of inflammatory responses by oncostatin M. J. Immunol. 162, 5547-5555.
10. BROWN, T.J., LUI, J., BRASHEM-STEIN, C., and SHOYAB, M. (1993). Regulation of G-CSF and GM-CSF expression by oncostatin M. Blood 82, 33-37.
11. BROWN, T.J., ROWE, J.M., LIU, J., and SHOYAB, M. (1991). Regulation of interleukin-6 expression by oncostatin M. J. Immunol. 147, 2175-2180.
12. LONGBIAO, Y., JUNLIANG, P., SETIADI, H., PATEL, K.D., and McEVER, P.E. (1996). Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J. Exp. Med. 184, 81-92.
13. MODUR, V., FELDHAUS, M.J., WEYRICH, A.S., JICHA, D.L., PRESCOTT, S.M., ZIMMERMAN, G.A., and McINTRYE, T.M. (1997). Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J. Clin. Invest. 100, 158-168.
14. RICHARDS, C.D., SHOYAB, M., BROWN, T.J., and GAULDIE, J. (1993). Selective regulation of metalloproteinases inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture. J. Immunol. 150, 5596-5603.
15. RICHARDS, C.D., LANGDON, C., BOTELHO, F., BROWN, T.J., and AGRO, A. (1996). Oncostatin M inhibits IL-1-induced expression of IL-8 and granulocyte-macrophage colony-stimulating factor by synovial and lung fibroblasts. J. Immunol. 156, 343-349.
16. TANAKA, M., HARA, T., COPELAND, D.L., GILBERT, D.J., JENKINS, N.A., and MIYAJIMA, A. (1999). Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor β subunit. Blood 93, 804-815.
17. KERR, C., LANGDON, C., GRAHAM, F.L., GAULDIE, J., HARA, T., and RICHARDS, C.D. (1999). Adenovirus vector expression mouse oncostatin M induces acute-phase proteins and TIMP-1 expression in vivo in mice. J. Interferon Cytokine Res. 19, 1195-1205.
18. BRACIAK, T.A., MITTAL, S.K., GRAHAM, F.L., RICHARDS, C.D., and GAULDIE, J. (1993). Construction of recombinant human type 5 adenovirus expressing rodent IL-6 genes. An approach to investigate in vivo cytokine function. J. Immunol. 151, 5145-5153.
19. DIAZ-GRANADOS, H., HOWE, K., LU, J., and McKAY, D.M. (2000). Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity. Am. J. Pathol. 156, 2169-2177.
20. OKAYASU, I., HATAKEYAMA, S., YAMADA, M., OHKUSA, T., INAGAKI, Y., and NAKAYA, R. (1990). A novel method in induction of reliable experimental acute and chronic colitis in mice. Gastroenterology 98, 694-702.
21. EGGER, B., BAJAJ-ELLIOTT, M., MacDONALD, T.T., INGLIN, R., EYSSELEIN, V.E., and BUCHLER, M.W. (2000). Characterization of acute murine dextran sodium sulphate colitis: cytokine profile and dose-dependency. Digestion 62, 240-248.
22. REARDON, C., SANCHEZ, A., HOGABOAM, C.M., and McKAY, D.M. (2001). Tapeworm infection reduces the ion transport abnormalities induced by dextran sulfate sodium (DSS) colitis. Infect. Immun. 69, 4417-4422.
23. APPLEYARD, C.B., and WALLACE, J.L. (1995). Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am. J. Physiol. (Gastrointest. Liver Physiol.) 269, G119-G125.
24. AUSTYN, J.M., and GORDON, S. (1981). F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11, 805-815.
25. INA, K., ITOH, J., FUKUSHIMA, K., KUSUGAMI, K., YAMAGUCHI, T., KYOKANE, K., IMADA, A., BINION, D.G., MUSSO, A., WEST, G.A., DOBREA, G.M., McCORMICK, T.S., LAPETINA, E.G., LEVINE, A.D., OTTAWAY, C.A., and FIOCCHI, C. (1999). Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J. Immunol. 163, 1081-1090.
26. DONNELLY, G.A.E., LU, J., TAKEDA, T., and McKAY, D.M. (1999). Colonic epithelial physiology is altered in response to the bacterial superantigen Yersinia pseudotuberculosis mitogen (YPM). J. Infect. Dis. 180, 1590-1596.
27. WEEKE, B. (1973). Rocket electrophoresis. Scand. J. Immunol. 1 (Suppl), 37-46.
28. BROWN, G.R., THIELE, D.L., SILVA, M., and BEUTLER, B. (1997). Adenoviral vectors given intravenously to immunocompromised mice yield stable transduction of the colonic epithelium. Gastroenterology 112, 1586-1594.
29. SHANAHAN, F. (2001). Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapies. Gastroenterology 120 (Suppl. 1), 622-635.
30. DIELEMAN, L.A., RIDWAN, B.U., TENNYSON, G.S., BEAGLEY, K.W., BUCY, R.P., and ELSON, C.O. (1994). Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107, 1643-1652.
31. SUZUKI, Y., SAITO, H., KASANUKI, J., KISHIMOTO, T., TAMURA, Y., and YOSHIDA, S. (1990). Significant increase of interleukin 6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease. Life Sci. 47, 2193-2197.
32. YAMAMOTO, M., YOSHIZAKI, K., KISHIMOTO, T., and ITO, H. (2000). IL-6 is required for the development of Th1 cell-mediated murine colitis. J. Immunol. 164, 4878-4882.
33. DEPORTERE, I., THIJS, T., VAN ASSCHE, G., KEITH, J.C., Jr., and PEETERS, T.L. (2000). Dose-dependent effects of recombinant human interleukin-11 on contractile properties in rabbit 2,4,6-trinitrobenzene sulphonic acid colitis. J. Pharmacol. Exp. Ther. 294, 983-990.
34. HURST, S.M., McLOUGHLIN, R.M., MONSLOW, J., OWENS, S., MORGAN, L., FULLER, G.M., TOPLEY, N., and JONES, S.A. (2002). Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells. J. Immunol. 169, 5244-5251.
35. BALDASSANO, R.N., SCHREIBER, S., JOHNSTON, R.B., FU, R.D., MURAKI, T., and MacDERMOTT, R.P. (1993). Crohn's disease monocytes are primed for accentuated release of toxic oxygen metabolites. Gastroenterology 105, 60-66.
36. RUGTVEIT, J., BRANDTZAEG, P., HALSTENSEN, T.S., FAUSA, O., and SCOTT, H. (1994). Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 35, 669-674.
37. ZAREIE, M., SINGH, P.K., IRVINE, J., SHERMAN, P.M., McKAY, D.M., and PERDUE, M.H. (2001). Monocyte/macrophage activation by normal bacteria and bacterial products: implications for epithelial pathophysiology in Crohn's disease. Am. J. Pathol. 158, 1101-1109.
38. + lymphocyte-associated Th2-type immune response in the intestine. J. Immunol. 164, 6303-6312.
39. PULIDO, E.J., SHAMES, B.D., PENNICA, D., O'LEARY, R.M., BENSARD, D.D., CAIN, B.S., and McINNTYRE, R.C., Jr. (1999). Cardiotrophin-1 attenuates endotoxin-induced acute lung injury. J. Surg. Res. 84, 240-246.
40. KERFOOT, S.M., RAHARJO, E., HO, M., KAUR, J., SERIROM, S., McCAFFERTY, D.M., BURNS, A.R., PATEL, K.D., and KUBES, P. (2001). Exclusive neutrophil recruitment with oncostation M in a human system. Am. J. Pathol. 195, 1531-1539.
41. LANGDON, C., KERR, C., HARA, T., ARSENAULT, A.L., and RICHARDS, C.D. (2000). Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am. J. Pathol. 157, 1187-1196.
42. LANGDON, C., KERR, C., TONG, L., and RICHARDS, C.D. (2003). Oncostatin M regulates eotaxin expression in fibroblasts and eosinophilic inflammation in C57BL/6 mice. J. Immunol. 170, 548-555.
43. BENIGNI, F., FANTUZZI, G., SACCO, S., SIRONI, M., POZZI, P., DINARELLO, C.A., SIPE, J.D., PLOI, V., CAPPELLETTI, M., PAONESSA, G., PENNICA, D., PANAYOTATOS, N., and GHEZZI, P. (1996). Six different cytokines that share the gp130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Blood 87, 1851-1860.
44. BARBARA, G., XING, Z., HOGABOAM, C.M., GAULDIE, J., and COLLINS, S.M. (2000). Interleukin 10 gene transfer prevents experimental colitis in rats. Gut 46, 344-349.
45. HOGABOAM, C.M., VALLANCE, B.A., KUMAR, A., ADDISON, C.L., GRAHAM, F.L., GAULDIE, J., and COLLINS, S.M. (1997). Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J. Clin. Invest. 100, 2766-2776.
46. LINDSAY, J.O., CIESIELSKI, C.J., SCHEININ, T., HODGSON, H.J., and BRENNAN, F.M. (2001). The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10. J. Immunol. 166, 7625-7633.
47. FOREMAN, P.K., WAINWRIGHT, M.J., ALICKE, B., KOVESDI, I., WICKHAM, T.J., SMITH, J.C., MEIER-DAVIS, S., FIX, J.A., DADDONA, P., GARDNER, P., and HUANG, M.T.F. (1998). Adenovirus-mediated transduction of intestinal cells in vivo. Hum. Gene Ther. 9, 1313-1321.
48. ARAI, Y., TAKANASHI, H., KITAGAWA, H., and OKAYASU, I. (1998). Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice. Cytokine 10, 890-896.
49. OBERMEIER, F., KOJOUHAROFF, G., HANS, W., SCHOLMERICH, J., GROSS, V., and FALK, W. (1999). Interferon-gamma (IFN-γ)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin. Exp. Immunol. 116, 238-245.